Brief: Bolt Biotherapeutics Reports Q4 Financial Results

Bolt Biotherapeutics

30/03/2022 21:15

March 30 (Reuters) - Bolt Biotherapeutics Inc  BOLT.O :
    * BOLT BIOTHERAPEUTICS REPORTS FOUR QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
    * QUARTERLY REVENUE $500,000
    * BOLT BIOTHERAPEUTICS - CASH, CASH EQUIVALENTS, MARKETABLE
SECURITIES WERE $271.6 MILLION AS OF DEC 31, 2021, COMPARED TO
$22.8 MILLION AS OF DEC 31, 2020
    * EXPECTS ITS CASH BALANCE TO FUND OPERATIONS INTO 2024

Source text for Eikon:  ID:nGNX3ndDB9 
Further company coverage:  BOLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))